NCT07111689Completed
The Effect of Virtual Reality on Cognitive Skills in Schizophrenia
Virtual Reality for Cognitive Enhancement in Schizophrenia: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 8 Aug 2025
Brief summary (registry, in English)
This study was conducted to examine the effect of virtual reality intervention, given in addition to conventional occupational therapy intervention, on general cognitive functions (attention, orientation, memory, visual skills, visual-motor skills, praxis, executive functions, etc.) in individuals with schizophrenia. This study was designed in accordance with the CONSORT statement, which standardizes randomized controlled trials. Additionally, the study was approved by a university's scientific research ethics committee.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 114 (actual)
- First submitted
- 1 Aug 2025
- Start date
- 1 Apr 2023
- Primary completion date
- 21 Oct 2023
- Lead sponsor
- Saglik Bilimleri Universitesi
- Diseases
- Schizophrenia
- NCT number
- NCT07111689
What you commit to
- Study type: Interventional
- Participants enrolled: 114
- From 1 Apr 2023 to the primary completion date, 21 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (1) Existence of additional diagnoses such as schizoaffective disorder, bipolar disorder or severe depressive disorder,
- (3) Presence of diseases that may affect cognitive functions such as epilepsy, dementia, Parkinson's disease,
- (7) There are conditions such as visual or hearing impairment that may prevent active participation
Other
- (2) Existence of active substance or alcohol addiction diagnosed in the last 6 months,
- (4) Exclusion of individuals who have active psychotic episodes or severe agitation during the study period,
- (5) Exclusion of individuals who are at risk of harming themselves or others,
- (6) For female participants, there is pregnancy or breastfeeding,
Who the study is looking for
- (1) age between 18 and 65 years,
- (2) Participants must have been diagnosed with Schizophrenia according to the ICD-10 diagnostic criteria,
- (3) Participants must be able to read and write at a level that will allow them to understand the content of the study,
- (4) There must be no severe cognitive impairment diagnosed that would prevent participation in the study,
- (5) Participants' antipsychotic treatments must be stable (no medication changes in the last 3 months),
- (6) Participants must be competent to provide informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Health Science Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.